Guilford, CT, United States of America

Samuel W Gerritz

This inventor holds 1 USPTO granted patent and 11 published patent applications. Top assignee: Halda Therapeutics Opco, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Samuel W. Gerritz

Introduction

Samuel W. Gerritz is an accomplished inventor based in Guilford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in treating diseases such as cancer. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Samuel W. Gerritz holds a patent for "Heterobifunctional compounds and their use in treating disease." This invention provides heterobifunctional compounds and pharmaceutical compositions that are instrumental in treating various diseases, including cancer. His patent reflects a commitment to advancing medical science and finding new solutions for complex health issues. He has 1 patent to his name.

Career Highlights

Gerritz is currently associated with Halda Therapeutics Opco, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His role at the company allows him to collaborate with other talented professionals and contribute to groundbreaking research and development.

Collaborations

Samuel has worked alongside notable colleagues such as James John Mousseau and Kyle J. Eastman. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions in the field of medicine.

Conclusion

Samuel W. Gerritz is a prominent inventor whose work in developing heterobifunctional compounds has the potential to make a significant impact on the treatment of diseases like cancer. His contributions to Halda Therapeutics Opco, Inc. and his collaborations with other professionals highlight his commitment to advancing healthcare through innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…